ARCHIVES

Are Cancer Drugs Getting Better? FDA’s Richard Pazdur Says “Yes”

This article is from The Cancer Letter archive.

Vol. 40 No. 07 | February 14, 2014

Download PDF Visit The Full Archive

Related Articles

Chemosensitivity, Resistance Assays Not Ready For Clinic, ASCO Tech Assessment Says

August 27, 2004

NCI Biostatistician Calls For Reanalysis Of Canadian Breast Screening Study

February 10, 1995

Also NCI Cancels von Eschenbach’s Farewell Party, Returns Gift Contributions Amid Ethics Questions.

May 19, 2006

NIH reauthorization Bill slates For House Vote;

May 28, 1993

Researchers Link Cancer Risk And DMPA Birth Control Use

April 27, 2012

Contract Proposal Would Assess Outcomes Other Than Incidence, Response, Mortality

September 18, 1987